| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/14/2007 | CN1929831A Methods for altering insulin secretion |
| 03/14/2007 | CN1929824A Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid |
| 03/14/2007 | CN1927888A Recombination albumen of GLP-1 and analogue thereof and human lysozyme fusion and application thereof |
| 03/14/2007 | CN1927848A Substituted acid compounds, preparation method and medicament use thereof |
| 03/14/2007 | CN1927386A Application of NYGGF5 protein and encoding gene thereof in preparation of medicine for inhibiting adipocyte differentiation |
| 03/14/2007 | CN1927341A Breviscapus pulse-engendering soft capsule and its preparing process |
| 03/14/2007 | CN1927335A Traditional medicine preparation for treating diabetic retinopathy |
| 03/14/2007 | CN1927334A Garlic powder health care capsule for reducing blood lipids and method for preparing same |
| 03/14/2007 | CN1927327A Composition comprising epalrestat |
| 03/14/2007 | CN1927310A Biological thrombolytic and antihyperglycemic nutrient solution and method for making same |
| 03/14/2007 | CN1927301A Tongmai Jiangzhi dispersant tablet and method for making same |
| 03/14/2007 | CN1927289A Pharmaceutical composition for treating diabetes and impaired glucose tolerance and its preparation |
| 03/14/2007 | CN1927223A Fat-reducing and beauty nourishing capsule |
| 03/14/2007 | CN1927222A Vanadium tonic comprising anion exchange resin as carrier, their preparation method and uses |
| 03/14/2007 | CN1927202A Vitamin E nicotinate microcapsule and its preparing process |
| 03/14/2007 | CN1927196A Preparing process for freeze-dried calcium gluconate powder injection |
| 03/14/2007 | CN1927188A Voltage endurance vitamin E microcapsule and its preparing process |
| 03/14/2007 | CN1927050A DHA microcapsule food additives, DHA soft capsule health product and uses thereof |
| 03/14/2007 | CN1304548C Health care wine containing dihydro-myricetin and myricetin composition |
| 03/14/2007 | CN1304406C Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |
| 03/14/2007 | CN1304393C Substituted pyrazolone derivatives and their preparing process and pharmaceutical conpositions |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/14/2007 | CN1304371C Heterocyclically substituted benzoylureas, their pharmaceuticals and use of preparing pharmaceuticals |
| 03/14/2007 | CN1304366C Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/14/2007 | CN1304073C Product capable of emitting far infrared and method of using far infrared |
| 03/14/2007 | CN1304048C Pharmaceutical compositions for oral delivery of pharmacologically active agents |
| 03/14/2007 | CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 03/14/2007 | CN1304039C Chinese medicine composition with functions of reducing blood-pressure, reducing-fat, anti-dizzy and calming wind, its preparing method and use |
| 03/14/2007 | CN1304036C Blood pressure reducing and blood fat removing healthy compositions |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1304008C Medical compsns. |
| 03/14/2007 | CN1303989C Zinc gluconate oral disintegrating tablet and its preparation process |
| 03/14/2007 | CN1303984C Method for prparing bee glue-ethyl cellulose microcapsule |
| 03/14/2007 | CN1303904C 橄榄钙片 Olive calcium |
| 03/13/2007 | US7189861 Ball milling any crystalline form of atorvastatin hemi-calcium to obtain a polymorphic crystal structure with small particle size distribution; monodispersity; improved physical properties of filtration/drying characteristics, flowability, vapor impermeability, solubility; drug-releasing design |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189809 Genetic engineered ioslated polynucleotide; anticholesterol agents, Alzheimer's disease, antilipemic agents |
| 03/13/2007 | US7189761 Nitric oxide donor composition and method for treatment of anal disorders |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189749 Substituted phenoxyacetic acids |
| 03/13/2007 | US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea |
| 03/13/2007 | US7189733 Compositions and methods for inhibiting TGF-β |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189727 Guanidino compounds |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189706 C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them |
| 03/13/2007 | US7189702 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 03/13/2007 | US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189518 Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases |
| 03/13/2007 | US7189412 Co-micronized with solid surfactant; contains lactose and magnesium stearate; mixture with binder and disintegrator; bioavailability |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2373128C Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/13/2007 | CA2365164C Method for selectively altering body fat level, feed efficiency, or weight gain |
| 03/13/2007 | CA2315227C Arylpiperazines having activity at the serotonin 1a receptor |
| 03/13/2007 | CA2274592C Pyrazole derivatives |
| 03/13/2007 | CA2274314C Insulin-like growth factor i (igf-i) expression system and methods of use |
| 03/13/2007 | CA2195053C Agents for inhibiting accumulation of visceral fat |
| 03/13/2007 | CA2192899C Composition containing l-carnitine and hydroxycitric acid |
| 03/08/2007 | WO2007028131A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 03/08/2007 | WO2007028082A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007027842A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 03/08/2007 | WO2007027733A2 Reverse link soft handoff in a wireless multiple-access communication system |
| 03/08/2007 | WO2007027569A1 Activated carbon and use thereof for reducing or maintaining body weight |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007026836A1 Novel therapeutic agent derived from marine organism |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007026761A1 Thiazole derivative |
| 03/08/2007 | WO2007026645A1 Dieting composition comprising plant-derived essential oil as active ingredient, sheet-type dieting composition comprising the composition, transdermal pharmaceutical preparation for dieting, and methods for production of the preparation |
| 03/08/2007 | WO2007026474A1 Nutrient composition |
| 03/08/2007 | WO2007026245A1 Novel composition |
| 03/08/2007 | WO2007026104A1 Pyrrolopyridine derivatives and use of same as ppar receptor modulators |
| 03/08/2007 | WO2007026097A1 Novel indole compounds |
| 03/08/2007 | WO2007025897A2 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 03/08/2007 | WO2007025892A1 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1 |
| 03/08/2007 | WO2007025349A1 Modulating ovulation and growth rates |
| 03/08/2007 | WO2007025332A1 A peptide and zinc ion composition for treating diabetes and enhancing immune function |
| 03/08/2007 | WO2007009686A3 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 03/08/2007 | WO2007003962A3 Gpcr agonists |
| 03/08/2007 | WO2006127893A3 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| 03/08/2007 | WO2006125178A3 Tricyclic pyridazine compounds and their uses as therapeutic agents |
| 03/08/2007 | WO2006124490A3 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| 03/08/2007 | WO2006117307A3 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 03/08/2007 | WO2006105455A3 Methods of treatment utilizing certain melatonin derivatives |
| 03/08/2007 | WO2006023295A3 Pharmaceutical compositions comprising effervescent agents and fenofibrate |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | US20070055050 Methods and reagents for diagnosis and treatment of diabetes |
| 03/08/2007 | US20070054950 3-Azabicyclo[3.1.0]hexane derivatives |
| 03/08/2007 | US20070054939 N-ethyl-N-(1-methyl-2-oxo-2-phenylethyl)2-[1(4'-trifluoromethylbiphenyl-2-carbonyl)piperid-4-yl]thiazole-4-carbamate ; hypertriglyceridaemia, hypercholesterolaemia, or dyslipidaemia associated with diabetes; microsomal triglyceride transfer protein (MTP), |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054895 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 03/08/2007 | US20070054891 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent, antidepressant; eating disorders, obesity, nicotine addiction |
| 03/08/2007 | US20070054888 Novel substituted diamine derivatives useful as motilin agonists |